1. Home
  2. MMA vs XLO Comparison

MMA vs XLO Comparison

Compare MMA & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMA
  • XLO
  • Stock Information
  • Founded
  • MMA 2013
  • XLO 2016
  • Country
  • MMA Australia
  • XLO United States
  • Employees
  • MMA N/A
  • XLO N/A
  • Industry
  • MMA
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMA
  • XLO Health Care
  • Exchange
  • MMA Nasdaq
  • XLO Nasdaq
  • Market Cap
  • MMA 34.2M
  • XLO 36.2M
  • IPO Year
  • MMA 2024
  • XLO 2021
  • Fundamental
  • Price
  • MMA $2.90
  • XLO $1.01
  • Analyst Decision
  • MMA
  • XLO
  • Analyst Count
  • MMA 0
  • XLO 0
  • Target Price
  • MMA N/A
  • XLO N/A
  • AVG Volume (30 Days)
  • MMA 8.7K
  • XLO 108.5K
  • Earning Date
  • MMA 08-05-2024
  • XLO 08-12-2024
  • Dividend Yield
  • MMA N/A
  • XLO N/A
  • EPS Growth
  • MMA N/A
  • XLO N/A
  • EPS
  • MMA N/A
  • XLO N/A
  • Revenue
  • MMA $1,018,293.00
  • XLO N/A
  • Revenue This Year
  • MMA N/A
  • XLO N/A
  • Revenue Next Year
  • MMA N/A
  • XLO $150.00
  • P/E Ratio
  • MMA N/A
  • XLO N/A
  • Revenue Growth
  • MMA N/A
  • XLO N/A
  • 52 Week Low
  • MMA $2.64
  • XLO $0.49
  • 52 Week High
  • MMA $5.25
  • XLO $2.94
  • Technical
  • Relative Strength Index (RSI)
  • MMA N/A
  • XLO 53.93
  • Support Level
  • MMA N/A
  • XLO $0.92
  • Resistance Level
  • MMA N/A
  • XLO $0.97
  • Average True Range (ATR)
  • MMA 0.00
  • XLO 0.06
  • MACD
  • MMA 0.00
  • XLO 0.01
  • Stochastic Oscillator
  • MMA 0.00
  • XLO 88.24

About MMA Alta Global Group Limited

Alta Global Group Ltd is a technology company that is enabling the global martial arts and combat sports industry to maximize the monetization opportunities available to the sector by increasing consumer participation in the sport and building upon existing community offerings within the sector. The Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: